XML 44 R33.htm IDEA: XBRL DOCUMENT

Related Party Disclosures	3 Months Ended
Related Party Disclosures	Mar. 31, 2019
Related Party Transactions [Abstract]
Related Party Disclosures	Related Party Disclosures The Company provides consulting services to PharmaCord, LLC. One of the Company’s directors, Nitin Sahney, is the member-manager and chief executive officer of PharmaCord, LLC. The Company recognized revenue of $nil and $199 in the three months ended March 31, 2019 and 2018, respectively, for services provided. As of March 31, 2019 and December 31, 2018, the Company had accounts receivable of $nil and $5, respectively, related to these services. On October 1, 2018, the Company entered into the Investment Agreement with the Purchaser relating to the issuance to the Purchaser of $150,000 aggregate principal amount of the Notes. In connection with the investment, Vikram S. Pandit, Chairman and CEO of The Orogen Group LLC (an affiliate of the Purchaser), was appointed to Company’s Board of Directors. During the quarter ended March 31, 2019, the Company reimbursed $35 to The Orogen Group LLC in connection with legal costs. The Company had outstanding Notes with a principle amount of $150,000 as of March 31, 2019 and December 31, 2018 and interest accrued of $2,625 and $1,313 as of March 31, 2019 and December 31, 2018, respectively, related to the Investment Agreement. Refer Note 18 to the unaudited consolidated financial statements for details.